Last update 08 May 2025

Autologous Bone Marrow CD34+ Stem Cells (Emmes)

Overview

Basic Info

Drug Type
Hematopoietic stem cell therapy
Synonyms-
Target-
Action-
Mechanism
Stem cell replacements
Therapeutic Areas
Cardiovascular DiseasesEye Diseases
Active Indication
Retinal Vein Occlusion
Inactive Indication-
Originator Organization
The Emmes Co. LLCThe Emmes Co. LLC
Active Organization
The Emmes Co. LLCThe Emmes Co. LLC
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Autologous Bone Marrow CD34+ Stem Cells (Emmes)
NCT03981549
/ CompletedPhase 1/2
Phase I/II Randomized, Prospective, Double-masked, Sham-controlled Study of Intravitreal Autologous Bone Marrow CD34+ Stem Cell Therapy for Central Retinal Vein Occlusion
100 Clinical Results associated with Autologous Bone Marrow CD34+ Stem Cells (Emmes)
Login to view more data
100 Translational Medicine associated with Autologous Bone Marrow CD34+ Stem Cells (Emmes)
Login to view more data
100 Patents (Medical) associated with Autologous Bone Marrow CD34+ Stem Cells (Emmes)
Login to view more data
100 Deals associated with Autologous Bone Marrow CD34+ Stem Cells (Emmes)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Retinal Vein OcclusionPhase 2
United States
The Emmes Co. LLCThe Emmes Co. LLC
22 Oct 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT03981549 (TRUST, CTgov)
Phase 1/2
Retinal Vein Occlusion
16
(Immediate Cellular Therapy / Deferred Sham Therapy)
kgarneryni(qxjcedvpvj) = chbtmwfden niedzwtdlx (mincbujfig, khkswyvfrd - tlasflwgms)
View more
-
02 Dec 2024
(Immediate Sham Therapy / Deferred Cellular Therapy)
kgarneryni(qxjcedvpvj) = thdwunwklo niedzwtdlx (mincbujfig, jhuvntjixj - mxgqhqhncy)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free